Tissue Regenix Group plc (LON:TRX – Get Free Report)’s stock price passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 60.24 ($0.74) and traded as low as GBX 57 ($0.70). Tissue Regenix Group shares last traded at GBX 57.03 ($0.70), with a volume of 4,648 shares.
Tissue Regenix Group Trading Up 0.9 %
The company has a market cap of £42.03 million, a P/E ratio of -5,900.00 and a beta of 1.61. The firm’s 50 day moving average is GBX 58.44 and its two-hundred day moving average is GBX 60.24. The company has a quick ratio of 2.36, a current ratio of 3.74 and a debt-to-equity ratio of 35.69.
Tissue Regenix Group Company Profile
Tissue Regenix is a leading medical device company in regenerative medicine. The Company’s patented decellularisation technology (dCELL®) removes DNA and other cellular material from animal and human soft tissue, leaving an acellular tissue scaffold not rejected by the patient’s body that can be used to repair diseased or damaged body structures.
Read More
- Five stocks we like better than Tissue Regenix Group
- Overbought Stocks Explained: Should You Trade Them?
- 4 Social Media Stocks Set to Gain as TikTok Ban Looms
- How to Calculate Options Profits
- How Do Stock Buybacks Affect Shareholders?
- Basic Materials Stocks Investing
- JPMorgan Chase & Co. Stock Can Hit $300 This Year
Receive News & Ratings for Tissue Regenix Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tissue Regenix Group and related companies with MarketBeat.com's FREE daily email newsletter.
